Therapeutics for Severely Ill Inpatients with COVID-19 (TESICO)/ACTIV-3b - Clinical Trial
What is the Purpose of this Study?
We are doing this study to learn more about the study drugs and to see if it can help people with COVID-19 respiratory failure get better and go home faster.
COVID-19 and Respiratory failure
Who Can Participate in the Study?
Adults who have respiratory failure and have tested positive for COVID-19.
What is Involved?
If you choose to join this study, you will:
-Have a nasal swab
-Give blood samples
-Be randomly assigned to get study drug or a placebo (harmless inactive saline) through a vein in your arm
-Get Remdesivir, an antiviral medication being used to treat COVID-19
-Complete follow-up visits either on the phone or in-person